7TM Pharma

About:

7TM Pharma is a biotech company that discovers and develops drugs with a primary therapeutic focus on diabetes, asthma, and more.

Top Investors: Novo Holdings, Index Ventures, Alta Partners, SR One, Johnson & Johnson Development Corporation

Description:

7TM Pharma is a biotech company that discovers and develops drugs with a primary therapeutic focus on diabetes, gastrointestinal, metabolic, asthma, and vascular diseases. The company offers seven transmembrane-spanning receptors, including TM38837, a small molecule CB1 receptor antagonist; TM30339, a NPY Y4 selective agonist that is used within gastrointestinal disorders, and short bowel syndrome; and CRTH2 antagonist, an oral drug for inflammatory or respiratory diseases. 7TM Pharma was founded in 2000 and is based in Lyngby, Hovedstaden.